Dracen Pharmaceuticals is based in Baltimore. It has raised $40M in total funding. Latest round: Series A.
Dracen Pharmaceuticals is based in Baltimore. Dracen Pharmaceuticals has raised $40M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in March 2018. The round record for Dracen Pharmaceuticals runs through 2018; nothing later has been disclosed. Investors on record include Deerfield Management, Osage University Partners, i&i Prague. 3 distinct backers are named across the disclosed rounds.
Dracen Pharmaceuticals totals reflect disclosed capital only — undisclosed extensions and secondaries are excluded. Use the related companies in Baltimore below to benchmark round size and investor mix.
Company funding database · Investor directory · Founder database · Mega-rounds 2026
The Startup Fundraising Platform
Raise funds for your startup
Find the right investors and get real replies — instantly, powered by AI.
Takes 30 seconds · No credit card · Cancel anytime
Slide-by-slide guide